Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317481 · ClinicalTrials.gov registry record · NA
Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms
A NA study of Major Depressive Disorder and Bipolar Disorder, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 2
- Study locations
NCT05317481 is a NA study of Major Depressive Disorder and Bipolar Disorder that has completed, run by Yale University. The registered enrollment target is 65 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05317481, a NA study of Major Depressive Disorder and Bipolar Disorder, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to advance a non-pharmacologic suicide preventive intervention with wide dissemination potential as an innovative high-yield solution to reduce suicide rates. The investigators aim to achieve this with this study of Brain Emotion Circuitry Self-Monitoring and Regulation Therapy for Daily Rhythms (BE-SMART-DR), that provides self-directed strategies to regularize sleep and other DRs to reduce short-term suicide risk that can be used lifelong to potentially also reduce long-term suicide risk.
Conditions Studied
Interventions
- BEHAVIORAL BE-SMART-DR
- BEHAVIORAL psychoeducational control comparator condition (CC)
Study Locations (2)
Connecticut
- Magnetic Resonance Research Center - New Haven
- Mood Disorders Research Program - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05317481
The ClinicalTrials.gov registry entry for NCT05317481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (83% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which BE-SMART-DR is the first listed.
NCT05317481 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05317481 about?
NCT05317481 is a clinical study titled "Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms". The purpose of this study is to advance a non-pharmacologic suicide preventive intervention with wide dissemination potential as an innovative high-yield solution to reduce suicide rates. The investigators aim to achieve this with this study of Brain Emotion Circuitry Self-Monitoring and Regulation ...
What is the current status of trial NCT05317481?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2022-04-01. Estimated completion is 2025-03-31.
What conditions does trial NCT05317481 study?
This clinical trial studies the following conditions: Major Depressive Disorder, Bipolar Disorder, Suicide, Suicidal Ideation, Mood Disorders.
What interventions are being tested in trial NCT05317481?
The interventions under investigation include: BE-SMART-DR (BEHAVIORAL), psychoeducational control comparator condition (CC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05317481?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05317481 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.